Predictors of Outcome after Alcohol Septal Ablation Therapy in Patients with Hypertrophic Obstructive Cardiomyopathy

Circulation

Volumn 109, Issue 7, 2004, Pages 824-827

  Chang, Su Min ^a   Lakkis, Nasser M ^b   Franklin, Jennifer ^b   Spencer III, William H ^b   Nagueh, Sherif F ^b,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Ablation; Alcohol; Cardiomyopathy; Hypertrophy

Indexed keywords

ALCOHOL; CREATINE KINASE;

ADULT; ALCOHOL SEPTAL ABLATION; ARTICLE; CATHETER ABLATION; COLOR ULTRASOUND FLOWMETRY; CONTRAST ECHOCARDIOGRAPHY; CREATINE KINASE BLOOD LEVEL; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; ANGINA PECTORIS; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; DYSPNEA; ETHANOL; EXERCISE TOLERANCE; FEMALE; HEART CATHETERIZATION; HEART FAILURE, CONGESTIVE; HEART SEPTUM; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; SCLEROSING SOLUTIONS; SCLEROTHERAPY; SEX FACTORS; TREATMENT OUTCOME; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 1342288505     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000117089.99918.5A     Document Type: Article

References (10)

1. Maron MS, Olivotto J, Betocchi S, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic obstructive cardiomyopathy. N Engl J Med. 2003;348:295-303.
2. Sigwart U. Nonsurgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995;346:211-214.
3. Knight C, Kurbaan A, Seggewiss H, et al. Non surgical septal reduction for hypertrophic obstructive cardiomyopathy. Circulation. 1997;95:2075-2081.
4. Seggewiss H, Gleichmann U, Faber L, et al. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute result and 3 month follow up in 25 patients. J Am Coll Cardiol. 1998;31:252-258.
5. Lakkis NM, Nagueh SF, Kleiman NS, et al. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation. 1998;98:1750-1755.
6. Nagueh SF, Lakkis NM, Middleton KJ, et al. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation. 1999;99:254-261.
7. Lakkis N, Plana JC, Nagueh S, et al. Efficacy of nonsurgical septal reduction therapy in symptomatic patients with obstructive hypertrophic cardiomyopathy and provocable gradients. Am J Cardiol. 2001;88:583-586.
8. Faber L, Meissner A, Ziemssen P, et al. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients. Heart. 2000;83:326-331.
9. Mazur W, Nagueh SF, Lakkis NM, et al. Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation. 2001;103:1492-1496.
10. Flores-Ramirez R, Lakkis NM, Middleton KJ, et al. Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2001;37:208-214.